Is ArriVent BioPharma, Inc. (AVBP) a Buy, Sell, or Hold?
ArriVent BioPharma, Inc.
NASDAQ:AVBP
$32.54 USD
-$1.1 (-3.27%)
- Volume
- 293.31K
- Average Volume
- 548.21K
- Market Capitalization
- $1.52B
- P/E Ratio
- -9.22
- Dividend Yield
- 0.00%
- Price Target
- $45.00
- Year High
- $35.83
- Year Low
- $16.10
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $13.95
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-27.7% DOWNSIDE
$45.00 Price Target
UPSIDE/DOWNSIDE HIGH
-27.7% DOWNSIDE
$45.00 Price Target High
UPSIDE/DOWNSIDE LOW
-27.7% DOWNSIDE
$45.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Goldman Sachs | Corinne Johnson | $33 | $22.03 | 2025-07-10 05:03 AM | 49.8% |
| Citigroup | Yigal Nochomovitz | $36 | $27.925 | 2024-09-10 07:49 AM | 28.9% |
| H.C. Wainwright | Robert Burns | $36 | $28.035 | 2024-09-10 02:38 AM | 28.4% |
| H.C. Wainwright | Robert Burns | $30 | $23.62 | 2024-08-16 02:39 AM | 27.0% |
| Oppenheimer | Jeff Jones | $35 | $18.77 | 2024-07-22 03:05 AM | 86.5% |